| Ticker | $ Bought |
|---|---|
| call- bsx 100 @ 75 exp 04/17/2026 | 5,020,000 |
| johnson&johnson | 4,889,000 |
| waters corp | 4,467,000 |
| astrazeneca plc | 3,944,000 |
| regeneron pharmaceuticals | 3,091,000 |
| elevance health inc | 1,464,000 |
| cvs health corp | 1,436,000 |
| Ticker | % Inc. |
|---|---|
| humana inc. | 33.33 |
| merck & co | 33.33 |
| Ticker | % Reduced |
|---|---|
| encompass health corp | -70.00 |
| smith & nephew | -60.00 |
| mckesson corp | -55.56 |
| tenet healthcare | -46.67 |
| edwards lifesciences | -42.86 |
| abbott labs | -37.5 |
| univ health svc | -37.5 |
| state street spdr s&p biotech | -33.33 |
| Ticker | $ Sold |
|---|---|
| surgery partners inc | -3,090,000 |
| select medical holdings corp | -2,822,000 |
| novo-nordisk a/s | -3,816,000 |
| bruker corporation | -3,062,000 |
| medtronic inc | -4,323,000 |
| bio-techne corp | -2,646,000 |
| astrazeneca plc-spons adr | -3,677,000 |
| cg oncology inc | -1,453,000 |
Sivik Global Healthcare LLC has about 76.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 76.8 |
| Others | 23.2 |
Sivik Global Healthcare LLC has about 77.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 61.1 |
| UNALLOCATED | 19.5 |
| MEGA-CAP | 16 |
| MID-CAP | 2.2 |
| NANO-CAP | 1.2 |
About 69.5% of the stocks held by Sivik Global Healthcare LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 69.5 |
| Others | 30.5 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Sivik Global Healthcare LLC has 33 stocks in it's portfolio. About 45.8% of the portfolio is in top 10 stocks. BSX proved to be the most loss making stock for the portfolio. BIL was the most profitable stock for Sivik Global Healthcare LLC last quarter.
Last Reported on: 15 Apr, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| A | agilent technologies inc | 2.60 | 30,000 | 3,419,000 | reduced | -14.29 | ||
| ABBV | abbvie inc | 2.48 | 15,000 | 3,262,000 | reduced | -25.00 | ||
| ABC | cencora inc | 3.58 | 15,000 | 4,712,000 | reduced | -16.67 | ||
| ABT | abbott labs | 1.95 | 25,000 | 2,567,000 | reduced | -37.5 | ||
| ALNY | alnylam pharmaceuticals | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANTX | elevance health inc | 1.11 | 5,000 | 1,464,000 | new | |||
| ARGX | argen se - adr | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AZN | astrazeneca plc-spons adr | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BDX | becton dickinson co | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BIIB | biogen inc | 2.09 | 15,000 | 2,750,000 | reduced | -25.00 | ||
| BIL | state street spdr s&p biotech | 14.55 | 150,000 | 19,160,000 | reduced | -33.33 | ||
| BIO | bio-rad labs a | 2.12 | 10,000 | 2,788,000 | reduced | -16.67 | ||
| BRKR | bruker corporation | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BSX | boston scientific corporation | 2.96 | 62,000 | 3,891,000 | reduced | -11.43 | ||
| CAH | cardinal health | 3.85 | 24,000 | 5,071,000 | reduced | -26.15 | ||
| CVS | cvs health corp | 1.09 | 20,000 | 1,436,000 | new | |||
| DHR | danaher corp | 2.88 | 20,000 | 3,792,000 | reduced | -13.04 | ||
| EHC | encompass health corp | 1.10 | 15,000 | 1,451,000 | reduced | -70.00 | ||
| EW | edwards lifesciences | 1.22 | 20,000 | 1,602,000 | reduced | -42.86 | ||
| GILD | gilead sciences inc | 2.65 | 25,000 | 3,484,000 | unchanged | 0.00 | ||